يعرض 1 - 10 نتائج من 13 نتيجة بحث عن '"Dalla Man, Chiara"', وقت الاستعلام: 1.55s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المصدر: IEEE Transactions on Biomedical Engineering. 71(3)

    الوصف: OBJECTIVE: Modeling the effect of meal composition on glucose excursion would help in designing decision support systems (DSS) for type 1 diabetes (T1D) management. In fact, macronutrients differently affect post-prandial gastric retention (GR), rate of appearance (R[Formula: see text]), and insulin sensitivity (S[Formula: see text]). Such variables can be estimated, in inpatient settings, from plasma glucose (G) and insulin (I) data using the Oral glucose Minimal Model (OMM) coupled with a physiological model of glucose transit through the gastrointestinal tract (reference OMM, R-OMM). Here, we present a model able to estimate those quantities in daily-life conditions, using minimally-invasive (MI) technologies, and validate it against the R-OMM. METHODS: Forty-seven individuals with T1D (weight =78±13 kg, age =42±10 yr) underwent three 23-hour visits, during which G and I were frequently sampled while wearing continuous glucose monitoring (CGM) and insulin pump (IP). Using a Bayesian Maximum A Posteriori estimator, R-OMM was identified from plasma G and I measurements, and MI-OMM was identified from CGM and IP data. RESULTS: The MI-OMM fitted the CGM data well and provided precise parameter estimates. GR and R[Formula: see text] model parameters were not significantly different using the MI-OMM and R-OMM (p 0.05) and the correlation between the two S[Formula: see text] was satisfactory ( ρ =0.77). CONCLUSION: The MI-OMM is usable to estimate GR, R[Formula: see text], and S[Formula: see text] from data collected in real-life conditions with minimally-invasive technologies. SIGNIFICANCE: Applying MI-OMM to datasets where meal compositions are available will allow modeling the effect of each macronutrient on GR, R[Formula: see text], and S[Formula: see text]. DSS could finally exploit this information to improve diabetes management.

    وصف الملف: application/pdf

  2. 2
    دورية أكاديمية

    المصدر: Diabetes. 61(9)

    الوصف: Insulin is secreted as discrete insulin secretory bursts at ~5-min intervals into the hepatic portal vein, these pulses being attenuated early in the development of type 1 and type 2 diabetes mellitus (T2DM). Intraportal insulin infusions (pulsatile, constant, or reproducing that in T2DM) indicated that the pattern of pulsatile insulin secretion delivered via the portal vein is important for hepatic insulin action and, therefore, presumably for hepatic insulin signaling. To test this, we examined hepatic insulin signaling in rat livers exposed to the same three patterns of portal vein insulin delivery by use of sequential liver biopsies in anesthetized rats. Intraportal delivery of insulin in a constant versus pulsatile pattern led to delayed and impaired activation of hepatic insulin receptor substrate (IRS)-1 and IRS-2 signaling, impaired activation of downstream insulin signaling effector molecules AKT and Foxo1, and decreased expression of glucokinase (Gck). We further established that hepatic Gck expression is decreased in the HIP rat model of T2DM, a defect that correlated with a progressive defect of pulsatile insulin secretion. We conclude that the physiological pulsatile pattern of insulin delivery is important in hepatic insulin signaling and glycemic control. Hepatic insulin resistance in diabetes is likely in part due to impaired pulsatile insulin secretion.

    وصف الملف: application/pdf

  3. 3
    دورية أكاديمية

    المساهمون: Adams, Jon D, Egan, Aoife M, Laurenti, Marcello C, Schembri Wismayer, Daniel, Bailey, Kent R, Cobelli, Claudio, Dalla Man, Chiara, Vella, Adrian

    الوصف: Background: The rs7903146 variant in the TCF7L2 gene is associated with defects in postprandial insulin and glucagon secretion and increased risk of type 2 diabetes. However, it is unclear if this variant has effects on glucose metabolism that are independent of islet function. Methods: We studied 54 nondiabetic subjects on two occasions where endogenous hormone secretion was inhibited by somatostatin. Twenty-nine subjects were homozygous for the diabetes-associated allele (TT) and 25 for the diabetes-protective allele (CC) at rs7903146, but otherwise matched for anthropometric characteristics. On 1 day, glucagon infused at a rate of 0.65 ng/kg/min, and at 0 min prevented a fall in glucagon (nonsuppressed day). On the contrary, infusion commenced at 120 min to create a transient fall in glucagon (suppressed day). Subjects received glucose (labeled with [3-3H]-glucose) infused to mimic the systemic appearance of oral glucose. Insulin was infused to mimic a prandial insulin response. Endogenous glucose production (EGP) was measured using the tracer dilution technique. Results: Lack of glucagon suppression increased postchallenge glucose concentrations and impaired EGP suppression. However, in the presence of matched insulin and glucagon concentrations, genetic variation in TCF7L2 did not alter glucose metabolism. Conclusion: These data suggest that genetic variation in TCF7L2 alters glucose metabolism through changes in islet hormone secretion.

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35442800; info:eu-repo/semantics/altIdentifier/wos/WOS:000791311600001; volume:20; issue:6; firstpage:329; lastpage:335; numberofpages:7; journal:METABOLIC SYNDROME AND RELATED DISORDERS; http://hdl.handle.net/11577/3456004Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85136341434

  4. 4
    دورية أكاديمية

    الوصف: OBJECTIVE: To compare two validated closed-loop (CL) algorithms versus patient self-control with CSII in terms of glycemic control. RESEARCH DESIGN AND METHODS: This study was a multicenter, randomized, three-way crossover, open-label trial in 48 patients with type 1 diabetes mellitus for at least 6 months, treated with continuous subcutaneous insulin infusion. Blood glucose was controlled for 23 h by the algorithm of the Universities of Pavia and Padova with a Safety Supervision Module developed at the Universities of Virginia and California at Santa Barbara (international artificial pancreas [iAP]), by the algorithm of University of Cambridge (CAM), or by patients themselves in open loop (OL) during three hospital admissions including meals and exercise. The main analysis was on an intention-to-treat basis. Main outcome measures included time spent in target (glucose levels between 3.9 and 8.0 mmol/L or between 3.9 and 10.0 mmol/L after meals). RESULTS: Time spent in the target range was similar in CL and OL: 62.6% for OL, 59.2% for iAP, and 58.3% for CAM. While mean glucose level was significantly lower in OL (7.19, 8.15, and 8.26 mmol/L, respectively) (overall P = 0.001), percentage of time spent in hypoglycemia (<3.9 mmol/L) was almost threefold reduced during CL (6.4%, 2.1%, and 2.0%) (overall P = 0.001) with less time ≤2.8 mmol/L (overall P = 0.038). There were no significant differences in outcomes between algorithms. CONCLUSIONS: Both CAM and iAP algorithms provide safe glycemic control.

    وصف الملف: Print-Electronic; application/pdf

  5. 5
    دورية أكاديمية

    المساهمون: DALLA MAN, Chiara, Micheletto, Francesco, Sathananthan, Matheni, Vella, Adrian, Cobelli, Claudio

    الوصف: Background: Glucagon-like peptide-1 (GLP-1) is a powerful insulin secretagogue that is secreted in response to meal ingestion. The ability to quantify the effect of GLP-1 on insulin secretion could provide insights into the pathogenesis and treatment of diabetes. We used a modification of a model of GLP-1 action on insulin secretion using data from a hyperglycemic clamp with concomitant GLP-1 infusion. We tested this model using data from a mixed meal test (MMT), thereby measuring GLP-1-induced potentiation of insulin secretion in response to a meal. Materials and Methods: The GLP-1 model is based on the oral C-peptide minimal model and assumes that over-basal insulin secretion depends linearly on GLP-1 concentration through the parameter , representing the -cell sensitivity to GLP-1. The model was tested on 62 subjects across the spectrum of glucose tolerance (age, 531 years; body mass index, 29.70.6kg/m(2)) studied with an MMT and provided a precise estimate of both -cell responsivity and indices. By combining with a measure of L-cell responsivity to glucose, one obtains a potentiation index (PI) (i.e., a measure of the L-cell's function in relation to prevailing -cell sensitivity to GLP-1). Results: Model-based measurement of GLP-1-induced insulin secretion demonstrates that the PI is significantly reduced in people with impaired glucose tolerance, compared with those with normal glucose tolerance. Conclusions: We describe a model that can quantitate the GLP-1-based contribution to insulin secretion in response to meal ingestion. This methodology will allow a better understanding of -cell function at various stages of glucose tolerance.

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/26756104; info:eu-repo/semantics/altIdentifier/wos/WOS:000368014600008; volume:18; issue:1; firstpage:39; lastpage:46; numberofpages:8; journal:DIABETES TECHNOLOGY & THERAPEUTICS; http://hdl.handle.net/11577/3229367Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84954429527; www.liebertonline.com/dia

  6. 6

    المصدر: Obesity (Silver Spring, Md.)

    الوصف: Objective To explore the role of MTNR1B rs10830963 and G6PC2 rs560887 variants in the pathogenesis of impaired fasting glucose (IFG) in obese adolescents. Design and Methods 346 Caucasians, 218 African Americans and 217 Hispanics obese children and adolescents underwent an oral glucose tolerance test (OGTT) and 518 underwent the evaluation of insulin secretion by the oral minimal model (OMM). Also, 274 subjects underwent a second OGTT after 3.0±2.1 years. Results The MTNR1B rs10830963 variant was associated with higher fasting glucose levels and lower dynamic beta cell response in Caucasians and Hispanics (p0.10). Conclusions We show for the first time in obese youth that the MTNR1B variant is associated with an increased risk of IFG.

  7. 7
    دورية أكاديمية

    المساهمون: Visentin, Roberto, DALLA MAN, Chiara, Kudva, Yogish C., Basu, Ananda, Cobelli, Claudio

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/25531427; info:eu-repo/semantics/altIdentifier/wos/WOS:000347538900001; volume:17; issue:1; firstpage:1; lastpage:7; numberofpages:7; journal:DIABETES TECHNOLOGY & THERAPEUTICS; http://hdl.handle.net/11577/3167755Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84920842830; www.liebertonline.com/dia

  8. 8
    دورية أكاديمية

    المساهمون: DALLA MAN, Chiara, Pillonetto, Gianluigi, Riz, Michela, Cobelli, Claudio

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/25852005; info:eu-repo/semantics/altIdentifier/wos/WOS:000356256100005; volume:308; issue:11; firstpage:E971; lastpage:E977; numberofpages:7; journal:AMERICAN JOURNAL OF PHYSIOLOGY: ENDOCRINOLOGY AND METABOLISM; http://hdl.handle.net/11577/3167749Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84930833063; http://ajpendo.physiology.org/content/ajpendo/308/11/E971.full.pdfTest

  9. 9
    دورية أكاديمية

    المساهمون: Javed, Asma, Vella, Adrian, Balagopal, P. Babu, Fischer, Philip R, Weaver, Amy L, Piccinini, Francesca, DALLA MAN, Chiara, Cobelli, Claudio, Giesler, Paula D, Laugen, Jeanette M, Kumar, Seema

    الوصف: There is increasing interest in the extraskeletal effects of vitamin D, particularly in the obese state with regard to the development of insulin resistance and diabetes.

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/25644349; info:eu-repo/semantics/altIdentifier/wos/WOS:000349057200014; volume:145; issue:2; firstpage:284; lastpage:290; numberofpages:7; journal:JOURNAL OF NUTRITION; http://hdl.handle.net/11577/3167753Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84964262316

  10. 10
    دورية أكاديمية

    المساهمون: Mallad, Ashwini, Hinshaw, Ling, Schiavon, Michele, DALLA MAN, Chiara, Dadlani, Vikash, Basu, Rita, Lingineni, Ravi, Cobelli, Claudio, Johnson, Matthew L., Carter, Rickey, Kudva, Yogish C., Basu, Ananda

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/25898950; info:eu-repo/semantics/altIdentifier/wos/WOS:000356259500007; volume:308; issue:12; firstpage:E1106; lastpage:E1115; numberofpages:10; journal:AMERICAN JOURNAL OF PHYSIOLOGY: ENDOCRINOLOGY AND METABOLISM; http://hdl.handle.net/11577/3167748Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84931039420; http://ajpendo.physiology.org/content/ajpendo/308/12/E1106.full.pdfTest